152 related articles for article (PubMed ID: 26314326)
21. Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance.
Dong X; Lin D; Low C; Vucic EA; English JC; Yee J; Murray N; Lam WL; Ling V; Lam S; Gout PW; Wang Y
J Thorac Oncol; 2013 Feb; 8(2):161-70. PubMed ID: 23287853
[TBL] [Abstract][Full Text] [Related]
22. Delta-tocotrienol augments cisplatin-induced suppression of non-small cell lung cancer cells via inhibition of the Notch-1 pathway.
Ji X; Wang Z; Sarkar FH; Gupta SV
Anticancer Res; 2012 Jul; 32(7):2647-55. PubMed ID: 22753722
[TBL] [Abstract][Full Text] [Related]
23. Rituximab modifies the cisplatin-mitochondrial signaling pathway, resulting in apoptosis in cisplatin-resistant non-Hodgkin's lymphoma.
Alas S; Ng CP; Bonavida B
Clin Cancer Res; 2002 Mar; 8(3):836-45. PubMed ID: 11895917
[TBL] [Abstract][Full Text] [Related]
24. Resveratrol Inhibited Non-small Cell Lung Cancer Through Inhibiting STAT-3 Signaling.
Li X; Wang D; Zhao QC; Shi T; Chen J
Am J Med Sci; 2016 Nov; 352(5):524-530. PubMed ID: 27865301
[TBL] [Abstract][Full Text] [Related]
25. Chan-Yu-Bao-Yuan-Tang induces apoptosis in NSCLC and SCLC cell lines via a mitochondria-mediated pathway.
Zhang Y; Zeng F; Liu X; Li Y; Zhou J; Huang Y; Wang Y; Zhou S; Zhu W; Shu E; Zhou G; Chen G
Xenobiotica; 2011 Jul; 41(7):593-602. PubMed ID: 21446835
[TBL] [Abstract][Full Text] [Related]
26. Highly sensitive and selective anticancer effect by conjugated HA-cisplatin in non-small cell lung cancer overexpressed with CD44.
Quan YH; Kim B; Park JH; Choi Y; Choi YH; Kim HK
Exp Lung Res; 2014 Dec; 40(10):475-84. PubMed ID: 25299431
[TBL] [Abstract][Full Text] [Related]
27. Investigation of the mechanism and apoptotic pathway induced by 4β cinnamido linked podophyllotoxins against human lung cancer cells A549.
Kamal A; Nayak VL; Bagul C; Vishnuvardhan MV; Mallareddy A
Apoptosis; 2015 Nov; 20(11):1518-29. PubMed ID: 26386574
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of Smac promotes Cisplatin-induced apoptosis by activating caspase-3 and caspase-9 in lung cancer A549 cells.
Qin S; Yang C; Wang X; Xu C; Li S; Zhang B; Ren H
Cancer Biother Radiopharm; 2013 Mar; 28(2):177-82. PubMed ID: 23252748
[TBL] [Abstract][Full Text] [Related]
29. Resveratrol induces apoptosis associated with mitochondrial dysfunction in bladder carcinoma cells.
Lin X; Wu G; Huo WQ; Zhang Y; Jin FS
Int J Urol; 2012 Aug; 19(8):757-64. PubMed ID: 22607368
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms of apoptotic effects induced by resveratrol, dibenzoylmethane, and their analogues on human lung carcinoma cells.
Weng CJ; Yang YT; Ho CT; Yen GC
J Agric Food Chem; 2009 Jun; 57(12):5235-43. PubMed ID: 19441815
[TBL] [Abstract][Full Text] [Related]
31. Flavokawain B induces apoptosis of non-small cell lung cancer H460 cells via Bax-initiated mitochondrial and JNK pathway.
An J; Gao Y; Wang J; Zhu Q; Ma Y; Wu J; Sun J; Tang Y
Biotechnol Lett; 2012 Oct; 34(10):1781-8. PubMed ID: 22729748
[TBL] [Abstract][Full Text] [Related]
32. TNF-related apoptosis-inducing ligand enhances vinorelbine-induced apoptosis and antitumor activity in a preclinical model of non-small cell lung cancer.
Zhu K; Fang W; Chen Y; Lin S; Chen X
Oncol Rep; 2014 Sep; 32(3):1234-42. PubMed ID: 25017445
[TBL] [Abstract][Full Text] [Related]
33. Anti-tumor effects of bakuchiol, an analogue of resveratrol, on human lung adenocarcinoma A549 cell line.
Chen Z; Jin K; Gao L; Lou G; Jin Y; Yu Y; Lou Y
Eur J Pharmacol; 2010 Sep; 643(2-3):170-9. PubMed ID: 20599920
[TBL] [Abstract][Full Text] [Related]
34. The use of mitochondrial targeting resveratrol liposomes modified with a dequalinium polyethylene glycol-distearoylphosphatidyl ethanolamine conjugate to induce apoptosis in resistant lung cancer cells.
Wang XX; Li YB; Yao HJ; Ju RJ; Zhang Y; Li RJ; Yu Y; Zhang L; Lu WL
Biomaterials; 2011 Aug; 32(24):5673-87. PubMed ID: 21550109
[TBL] [Abstract][Full Text] [Related]
35. Resveratrol-loaded folic acid-grafted dextran stearate submicron particles exhibits enhanced antitumor efficacy in non-small cell lung cancers.
Zhao QS; Hu LL; Wang ZD; Li ZP; Wang AW; Liu J
Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():185-191. PubMed ID: 28024576
[TBL] [Abstract][Full Text] [Related]
36. Sodium valproate, a histone deacetylase inhibitor, enhances the efficacy of vinorelbine-cisplatin-based chemoradiation in non-small cell lung cancer cells.
Gavrilov V; Lavrenkov K; Ariad S; Shany S
Anticancer Res; 2014 Nov; 34(11):6565-72. PubMed ID: 25368259
[TBL] [Abstract][Full Text] [Related]
37. Resveratrol enhances radiosensitivity of human non-small cell lung cancer NCI-H838 cells accompanied by inhibition of nuclear factor-kappa B activation.
Liao HF; Kuo CD; Yang YC; Lin CP; Tai HC; Chen YY; Chen YJ
J Radiat Res; 2005 Dec; 46(4):387-93. PubMed ID: 16394628
[TBL] [Abstract][Full Text] [Related]
38. Emodin enhances cisplatin-induced cytotoxicity via down-regulation of ERCC1 and inactivation of ERK1/2.
Ko JC; Su YJ; Lin ST; Jhan JY; Ciou SC; Cheng CM; Chiu YF; Kuo YH; Tsai MS; Lin YW
Lung Cancer; 2010 Aug; 69(2):155-64. PubMed ID: 19962780
[TBL] [Abstract][Full Text] [Related]
39. Ferruginol inhibits non-small cell lung cancer growth by inducing caspase-associated apoptosis.
Ho ST; Tung YT; Kuo YH; Lin CC; Wu JH
Integr Cancer Ther; 2015 Jan; 14(1):86-97. PubMed ID: 25355727
[TBL] [Abstract][Full Text] [Related]
40. Betulin induces mitochondrial cytochrome c release associated apoptosis in human cancer cells.
Li Y; He K; Huang Y; Zheng D; Gao C; Cui L; Jin YH
Mol Carcinog; 2010 Jul; 49(7):630-40. PubMed ID: 20564340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
